Moors & Cabot Inc. Has $508,000 Stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Moors & Cabot Inc. reduced its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 24.1% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 42,003 shares of the pharmacy operator’s stock after selling 13,333 shares during the quarter. Moors & Cabot Inc.’s holdings in Walgreens Boots Alliance were worth $508,000 as of its most recent filing with the SEC.

Several other large investors also recently modified their holdings of WBA. Capital World Investors increased its position in shares of Walgreens Boots Alliance by 57.5% during the first quarter. Capital World Investors now owns 29,061,021 shares of the pharmacy operator’s stock worth $630,334,000 after buying an additional 10,612,373 shares during the period. Thompson Siegel & Walmsley LLC lifted its position in shares of Walgreens Boots Alliance by 98.8% during the 2nd quarter. Thompson Siegel & Walmsley LLC now owns 6,021,126 shares of the pharmacy operator’s stock valued at $72,826,000 after acquiring an additional 2,992,648 shares during the period. Norges Bank acquired a new stake in Walgreens Boots Alliance in the fourth quarter worth $29,816,000. Swedbank AB bought a new stake in Walgreens Boots Alliance in the first quarter valued at $16,365,000. Finally, Minneapolis Portfolio Management Group LLC acquired a new position in shares of Walgreens Boots Alliance during the first quarter valued at about $13,710,000. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

WBA has been the topic of a number of research reports. Morgan Stanley dropped their price target on Walgreens Boots Alliance from $13.00 to $9.00 and set an “underweight” rating on the stock in a research note on Friday, June 28th. Bank of America cut their target price on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating on the stock in a report on Wednesday, September 4th. TD Cowen decreased their price target on shares of Walgreens Boots Alliance from $22.00 to $16.00 and set a “buy” rating for the company in a research note on Thursday, September 12th. Truist Financial reduced their price objective on shares of Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating for the company in a report on Friday, June 28th. Finally, Barclays lowered their target price on shares of Walgreens Boots Alliance from $11.00 to $7.00 and set an “underweight” rating on the stock in a report on Tuesday, July 23rd. Four analysts have rated the stock with a sell rating, ten have issued a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $14.73.

Walgreens Boots Alliance Stock Performance

Shares of Walgreens Boots Alliance stock opened at $8.98 on Friday. The business’s fifty day simple moving average is $10.35 and its 200 day simple moving average is $14.85. The company has a current ratio of 0.65, a quick ratio of 0.31 and a debt-to-equity ratio of 0.49. Walgreens Boots Alliance, Inc. has a 12 month low of $8.46 and a 12 month high of $27.05. The firm has a market capitalization of $7.75 billion, a P/E ratio of -1.33, a price-to-earnings-growth ratio of 1.02 and a beta of 0.70.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.05). The company had revenue of $36.40 billion during the quarter, compared to analysts’ expectations of $35.94 billion. Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. Walgreens Boots Alliance’s quarterly revenue was up 2.8% compared to the same quarter last year. During the same period last year, the firm posted $1.00 earnings per share. As a group, analysts anticipate that Walgreens Boots Alliance, Inc. will post 2.86 EPS for the current year.

Walgreens Boots Alliance Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 12th. Investors of record on Wednesday, August 21st were paid a $0.25 dividend. The ex-dividend date was Wednesday, August 21st. This represents a $1.00 annualized dividend and a yield of 11.14%. Walgreens Boots Alliance’s payout ratio is -14.84%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.